|
HY-123099-25mg
|
MedChemexpress LLC
|
MS-1020 [CAS 1255516-86-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-114759-10mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-100mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-25mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-5mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-50mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-1mL
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-12288A-10mg
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288A-100mg
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288A-25mg
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288A-5mg
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288A-50mg
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288A-1mL
|
MedChemexpress LLC
|
Ozanimod (hydrochloride) [CAS 1618636-37-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-10mg
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-100mg
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-25mg
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-5mg
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-50mg
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12288-1mL
|
MedChemexpress LLC
|
Ozanimod [CAS 1306760-87-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-17424-100mg
|
MedChemexpress LLC
|
Penciclovir [CAS 39809-25-1]
|
|
COVID-19-anti-virus
|
|
|
HY-17424-50mg
|
MedChemexpress LLC
|
Penciclovir [CAS 39809-25-1]
|
|
COVID-19-anti-virus
|
|
|
HY-17424-1mL
|
MedChemexpress LLC
|
Penciclovir [CAS 39809-25-1] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-130584-100mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130584-250mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130584-50mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
